Zurich, Zurich, Switzerland
• Product profitability assessment through global market data analysis (industry databases) and economic models (International Reference Pricing, Cost-Effectiveness analysis, Country Launch Optimization). • Market Access projections in preparation Health Authority submissions through Key Opinion Leader engagement, synthesizing qualitative data into actionable strategic recommendations. • Developed product dossiers and value stories with impactful reports and dashboards.
• Scientific team coordination in the field of Organ-on-Chip (preclinical 3D in vitro systems) which led to the development of a platform for preclinical drug testing. • Presented complex scientific data and key findings at international conferences, awarded three times for impactful data visualization and clear communication. • Secured funding grants through convincing project pitches to technical and non-technical stakeholders. • Formative visiting period at a preclinical CRO (Accelera NMS group, Milan, Italy) to familiarize with CRO operations and client services in the drug development sector.
Gaining exposure to preclinical commercial services, especially on in vitro and DMPK ADME in vivo studies, enhancing understanding of CRO operations and client services in the drug development sector